Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Vaccine Policy
  • ‘Beyond Medical Necessity’ Hospital Stays
  • Trump’s Eli Lilly Stock Purchases
  • Changes Coming to ACA Exchanges
  • Texas ‘Detransition Clinic’

WHAT'S NEW

  • Vaccine Policy
  • 'Beyond Medical Necessity' Hospital Stays
  • Trump's Eli Lilly Stock Purchases
  • Changes Coming to ACA Exchanges
  • Texas 'Detransition Clinic'

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Jul 25 2019

Full Issue

Trump Cooking Up A Sweeping Executive Order That Would Cut Drug Prices In Medicare's Part D Program, Sources Say

According to reporting from Reuters, sources say the proposal would be much broader than the administration’s previously disclosed proposal to lower prices on physician administered, or Part B, drugs by tying prices to lower costs in other countries.

Reuters: Exclusive: White House Preparing Order That Would Cut Drug Prices For Medicare-Sources

U.S. President Donald Trump is considering a sweeping executive order that would cut prices on virtually all branded prescription drugs sold to Medicare and other government programs, according to two industry sources who had discussions with the White House. The order under discussion would be much broader than the Administration's previously disclosed proposal to lower prices on physician administered, or Part B, drugs by tying prices to lower costs in other countries. (Erman and O'Donnell, 7/24)

Politico Pro: Trump, Azar Meet With Pharma Executives At White House

President Donald Trump hosted pharmaceutical executives in the Oval Office today as his administration pursues a deal on drug pricing, four individuals with knowledge of the meeting told POLITICO. Steve Ubl, the CEO of PhRMA, was joined by representatives of Pfizer and Amgen. HHS Secretary Alex Azar and Domestic Policy Council chief Joe Grogan also attended the meeting, as well as House Majority Leader Kevin McCarthy and Rep. Mark Meadows (R-N.C.). (Diamond and Owermohle, 7/24)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, May 18
  • Friday, May 15
  • Thursday, May 14
  • Wednesday, May 13
  • Tuesday, May 12
  • Monday, May 11
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF